Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (100.0%)LMT503 First-in-human SAD, MAD, and FE Study
Phase 1
Not yet recruiting
- Conditions
- Colitis, UlcerativeCrohn DiseaseInflammatory Bowel Disease
- Interventions
- Drug: Placebo
- First Posted Date
- 2022-12-21
- Last Posted Date
- 2024-10-23
- Lead Sponsor
- Lmito Therapeutics Inc.
- Target Recruit Count
- 72
- Registration Number
- NCT05659953
- Locations
- 🇳🇱
ICON plc Company - Early Development Services, Groningen, NZ, Netherlands
News
No news found